• RM576 Save up to RM288 with the Yearly Premium Plan (Limited Time Only)
  • RM480 Save up to RM240 with the Yearly Advanced Plan (Limited Time Only)
Subscribe Now
premium Subscription Plan
add free StockBiz
YouTube MS Production

Last Price Change Volume
KLSE Market Watch
Open: Day Range: Prev Close:


NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : OTHER ISSUE OF SECURITIES DUOPHARMA BIOTECH BERHAD ("DUOPHARMA BIOTECH" OR THE "COMPANY") DIVIDEND REINVESTMENT PLAN ("DRP")

DUOPHARMA BIOTECH BERHAD

Type Announcement
Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
OTHER ISSUE OF SECURITIES
Description
DUOPHARMA BIOTECH BERHAD ("DUOPHARMA BIOTECH" OR THE "COMPANY")

DIVIDEND REINVESTMENT PLAN ("DRP")

On 23 February 2023, the Board of Directors of Duopharma Biotech (“Board”) declared a second interim dividend of 1.8 sen per ordinary share in Duopharma Biotech (“Duopharma Biotech Shares”) in respect of the financial year ended 31 December 2022 and resolved that the DRP, which was approved at the Company’s Extraordinary General Meeting held on 31 May 2018, would apply to the said second interim dividend. 

On behalf of the Board, AmInvestment Bank Berhad wishes to announce that the Company had on 15 March 2023 submitted an application to Bursa Malaysia Securities Berhad (“Bursa Securities”) for the listing and quotation of the new Duopharma Biotech Shares to be issued pursuant to the DRP on the Main Market of Bursa Securities.


This Announcement is dated 15 March 2023.






Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 15 Mar 2023
Category General Announcement for PLC
Reference Number GA1-15032023-00036



Close
New Feature
MS Academy
AI StockMaster. Beat The Market! Checking MS Signal
DETECT REAL-TIME STOCK MOVEMENT
X
(InvestorPro Plan Only)
Complimentary access on Premium Plan*
What is AI StockMaster?
Window Alert On-Screen Alert X
X